BACKGROUND: The GABRA2 gene has been implicated in addiction. Early life stress has been shown to alter GABRA2 expression in adult rodents. We hypothesized that childhood trauma, GABRA2 variation, and their interaction would influence addiction vulnerability. METHODS: African-American men were recruited for this study: 577 patients with lifetime DSM-IV single and comorbid diagnoses of alcohol, cocaine, and heroin dependence, and 255 control subjects. The Childhood Trauma Questionnaire (CTQ) was administered. Ten GABRA2 haplotype-tagging single-nucleotide polymorphisms (SNPs) were genotyped. RESULTS: We found that exposure to childhood trauma predicted substance dependence (p < .0001). Polysubstance dependence was associated with the highest CTQ scores (p < .0001). The African Americans had four common haplotypes (frequency: .11-.30) within the distal haplotype block: two that correspond to the Caucasian and Asian yin-yang haplotypes, and two not found in other ethnic groups. One of the unique haplotypes predicted heroin addiction, whereas the other haplotype was more common in control subjects and seemed to confer resilience to addiction after exposure to severe childhood trauma. The yin-yang haplotypes had no effects. Moreover, the intron 2 SNP rs11503014, not located in any haplotype block and potentially implicated in exon splicing, was independently associated with addiction, specifically heroin addiction (p < .005). Childhood trauma interacted with rs11503014 variation to influence addiction vulnerability, particularly to cocaine (p < .005). CONCLUSIONS: Our results suggest that at least in African-American men, childhood trauma, GABRA2 variation, and their interaction play a role in risk-resilience for substance dependence.
BACKGROUND: The GABRA2 gene has been implicated in addiction. Early life stress has been shown to alter GABRA2 expression in adult rodents. We hypothesized that childhood trauma, GABRA2 variation, and their interaction would influence addiction vulnerability. METHODS: African-American men were recruited for this study: 577 patients with lifetime DSM-IV single and comorbid diagnoses of alcohol, cocaine, and heroin dependence, and 255 control subjects. The Childhood Trauma Questionnaire (CTQ) was administered. Ten GABRA2 haplotype-tagging single-nucleotide polymorphisms (SNPs) were genotyped. RESULTS: We found that exposure to childhood trauma predicted substance dependence (p < .0001). Polysubstance dependence was associated with the highest CTQ scores (p < .0001). The African Americans had four common haplotypes (frequency: .11-.30) within the distal haplotype block: two that correspond to the Caucasian and Asian yin-yang haplotypes, and two not found in other ethnic groups. One of the unique haplotypes predicted heroin addiction, whereas the other haplotype was more common in control subjects and seemed to confer resilience to addiction after exposure to severe childhood trauma. The yin-yang haplotypes had no effects. Moreover, the intron 2 SNP rs11503014, not located in any haplotype block and potentially implicated in exon splicing, was independently associated with addiction, specifically heroin addiction (p < .005). Childhood trauma interacted with rs11503014 variation to influence addiction vulnerability, particularly to cocaine (p < .005). CONCLUSIONS: Our results suggest that at least in African-American men, childhood trauma, GABRA2 variation, and their interaction play a role in risk-resilience for substance dependence.
Authors: Amira Pierucci-Lagha; Jonathan Covault; Richard Feinn; Maggie Nellissery; Carlos Hernandez-Avila; Cheryl Oncken; A Leslie Morrow; Henry R Kranzler Journal: Neuropsychopharmacology Date: 2005-06 Impact factor: 7.853
Authors: Jonathan Covault; Joel Gelernter; Kevin Jensen; Raymond Anton; Henry R Kranzler Journal: Neuropsychopharmacology Date: 2007-05-16 Impact factor: 7.853
Authors: Colin A Hodgkinson; Qiaoping Yuan; Ke Xu; Pei-Hong Shen; Elizabeth Heinz; Elizabeth A Lobos; Elizabeth B Binder; Joe Cubells; Cindy L Ehlers; Joel Gelernter; John Mann; Brien Riley; Alec Roy; Boris Tabakoff; Richard D Todd; Zhifeng Zhou; David Goldman Journal: Alcohol Alcohol Date: 2008-05-12 Impact factor: 2.826
Authors: H V Morris; G R Dawson; D S Reynolds; J R Atack; T W Rosahl; D N Stephens Journal: Pharmacol Biochem Behav Date: 2008-02-12 Impact factor: 3.533
Authors: Joel Gelernter; Henry R Kranzler; Carolien Panhuysen; Roger D Weiss; Kathleen Brady; James Poling; Lindsay Farrer Journal: Biol Psychiatry Date: 2008-10-18 Impact factor: 13.382
Authors: Frederic Boy; C John Evans; Richard A E Edden; Andrew D Lawrence; Krish D Singh; Masud Husain; Petroc Sumner Journal: Biol Psychiatry Date: 2011-07-14 Impact factor: 13.382
Authors: Jacquelyn L Meyers; Jian Zhang; Niklas Manz; Madhavi Rangaswamy; Chella Kamarajan; Leah Wetherill; David B Chorlian; Sun J Kang; Lance Bauer; Victor Hesselbrock; John Kramer; Samuel Kuperman; John I Nurnberger; Jay Tischfield; Jen Chyong Wang; Howard J Edenberg; Alison Goate; Tatiana Foroud; Bernice Porjesz Journal: Int J Psychophysiol Date: 2016-12-28 Impact factor: 2.997
Authors: Emily M Drabant; Wiveka Ramel; Michael D Edge; Luke W Hyde; Janice R Kuo; Philippe R Goldin; Ahmad R Hariri; James J Gross Journal: Am J Psychiatry Date: 2012-04 Impact factor: 18.112
Authors: Joshua L Gowin; Charles E Green; Joseph L Alcorn; Alan C Swann; F Gerard Moeller; Scott D Lane Journal: J Psychopharmacol Date: 2011-07-05 Impact factor: 4.153
Authors: Laura E Kwako; Melanie L Schwandt; Vijay A Ramchandani; Nancy Diazgranados; George F Koob; Nora D Volkow; Carlos Blanco; David Goldman Journal: Am J Psychiatry Date: 2019-01-04 Impact factor: 18.112
Authors: Daniel E Irons; William G Iacono; William S Oetting; Robert M Kirkpatrick; Scott I Vrieze; Michael B Miller; Matt McGue Journal: Alcohol Clin Exp Res Date: 2014-01-24 Impact factor: 3.455